Study Shows that the Metastasis-Free Period Affects Prostate Cancer Patient Survival
A study from Michael T. Schweizer, MD, and colleagues at Johns Hopkins University in Baltimore Md. concluded that the longer the metastasis-free survival after a radical prostatectomy the longer overall survival in men who experience [...]
BRCA Mutations and Prostate Cancer
When Angelina Jolie's double mastectomy hit the headlines in May this year there was a lot of press coverage including discussions about BRCA 1 and 2 genes. These conversations centered on women and their risk [...]
Worthy New Immunotherapy Clinical Trial Opens at Johns Hopkins University for Men Thinking of Surgery
The exciting thing about Provenge is not only the real survival advantage that it offers with minimal side effects, but that it is a proof of concept treatment that is heralding in the potential [...]
Dr. Steals $35 Million Dollars and Assaults His Patients
Dr. Farid Fata, who owns Michigan Hematology Oncology which has six offices throughout Michigan in the cities of Clarkston, Bloomfield Hills, Lapeer, Sterling Heights, Troy and Oak Park is now out of jail, but he [...]
Additional Information on Patient Assistance Programs for Advanced Prostate Cancer
It has been brought to my attention that when I wrote the August 8, 2013 post on Pharma Sponsored Assistance Programs, I neglected to mention another excellent assistance program for men with advanced prostate cancer. [...]
Step Therapy with Zytiga & Xtandi – Two Equal Drugs Make Our Insurance Companies Our Doctors!
Recently men with advanced prostate cancer have found that their insurance companies have been dictating what drugs they can get instead of their doctor making the best decision for them. At Malecare we have seen [...]